重症急性胰腺炎入住ICU患者的静脉液体治疗:叙述性综述
该叙述性综述讨论重症急性胰腺炎(AP)入住ICU患者的静脉液体治疗。AP因胰腺大量释放促炎细胞因子引起全身炎症反应综合征和血管内液体大量丢失,导致混合性低血容量与分布性休克,最终多器官衰竭。所有现有指南均强调液体治疗的重要性,尤其在发病后首个24-48小时;但液体类型、最佳速率、总量或目标均无共识。一般推荐首个24小时以林格液5-10 ml/kg/h起始,早期积极补液,仅在适当时间窗内持续,通常在入院后首个24-48小时后停止或显著减少。需密切临床与血流动力学监测、明确复苏目标,公认目标为尿量、心动过速与低血压逆转及实验室指标改善,但不同终点的指导价值争议很大。多数指南认可密切监测输液与液体平衡以避免液体过负荷的有害效应。作者提出基于个体化方法的液体管理操作流程。
要点
- 所有现有指南均强调液体治疗在AP中的重要性,尤其在发病后首个24-48小时。
- 一般推荐首个24小时以林格液5-10 ml/kg/h起始,早期积极补液,通常在入院后首个24-48小时停止或显著减少。
- 液体类型、最佳速率、总量或目标目前均无共识,不同终点指导液体治疗的价值争议很大。
- 公认复苏目标为尿量、心动过速与低血压逆转及实验室指标改善。
- 多数指南认可密切监测输液与液体平衡,以避免液体过负荷的有害效应;重症AP应按脓毒症休克和烧伤等需大量补液的情况一样仔细个体化调整。
适用人群与场景
- 入住ICU的急性胰腺炎患者,尤其存在多器官衰竭体征即重症AP者。
- 重症AP因胰腺大量释放促炎细胞因子引起全身炎症反应综合征和血管内液体大量丢失,导致混合性低血容量与分布性休克,最终多器官衰竭。
处置流程与药物剂量
- 所有现有指南均强调液体治疗的重要性,尤其在发病后首个24-48小时。
- 一般推荐首个24小时以林格液5-10 ml/kg/h起始。
- 液体输注应在最初数小时积极,仅在适当时间窗内持续,通常在入院后首个24-48小时停止或显著减少。
- 需密切临床与血流动力学监测,并明确复苏目标。
- 公认目标为尿量、心动过速与低血压逆转及实验室指标改善。
- 多数指南认可密切监测输液与液体平衡,以避免液体过负荷的有害效应。
- 重症AP的液体治疗应像脓毒症休克和烧伤等ICU常见需大量补液的情况一样仔细个体化调整。
- 作者提出基于个体化方法的液体管理操作流程,结合无创临床参数、有创血流动力学参数和实验室标志物指导早期液体治疗,以满足器官灌注需求并避免液体过负荷。
红旗征与不能漏的情况
- 多器官衰竭体征提示AP为重症。
- 液体过负荷具有有害效应。
研究设计与关键结果
- 本文为叙述性综述,讨论重症AP液体治疗的最新证据并提出基于个体化方法的液体管理操作流程。
- 液体类型、最佳速率、总量或目标目前均无共识;不同终点指导液体治疗的价值争议很大。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 所有现有指南均强调液体治疗在AP中的重要性,尤其在发病后首个24-48小时,支持早期积极补液。
- 一般推荐首个24小时以林格液5-10 ml/kg/h起始,通常在入院后首个24-48小时停止或显著减少。
- 液体类型、速率、总量与目标无共识,临床需结合无创临床参数、有创血流动力学参数和实验室标志物个体化调整,并密切监测输液与液体平衡以避免液体过负荷。
- 作者提出基于个体化方法的液体管理操作流程。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Patients with acute pancreatitis (AP) often require ICU admission, especially when signs of multiorgan failure are present, a condition that defines AP as severe. This disease is characterized by a massive pancreatic release of pro-inflammatory cytokines that causes a systemic inflammatory response syndrome and a profound intravascular fluid loss. This leads to a mixed hypovolemic and distributive shock and ultimately to multiorgan failure. Aggressive fluid resuscitation is traditionally considered the mainstay treatment of AP. In fact, all available guidelines underline the importance of fluid therapy, particularly in the first 24-48 h after disease onset. However, there is currently no consensus neither about the type, nor about the optimal fluid rate, total volume, or goal of fluid administration. In general, a starting fluid rate of 5-10 ml/kg/h of Ringer's lactate solution for the first 24 h has been recommended. Fluid administration should be aggressive in the first hours, and continued only for the appropriate time frame, being usually discontinued, or significantly reduced after the first 24-48 h after admission. Close clinical and hemodynamic monitoring along with the definition of clear resuscitation goals are fundamental. Generally accepted targets are urinary output, reversal of tachycardia and hypotension, and improvement of laboratory markers. However, the usefulness of different endpoints to guide fluid therapy is highly debated. The importance of close monitoring of fluid infusion and balance is acknowledged by most available guidelines to avoid the deleterious effect of fluid overload. Fluid therapy should be carefully tailored in patients with severe AP, as for other conditions frequently managed in the ICU requiring large fluid amounts, such as septic shock and burn injury. A combination of both noninvasive clinical and invasive hemodynamic parameters, and laboratory markers should guide clinicians in the early phase of severe AP to meet organ perfusion requirements with the proper administration of fluids while avoiding fluid overload. In this narrative review the most recent evidence about fluid therapy in severe AP is discussed and an operative algorithm for fluid administration based on an individualized approach is proposed.
参考来源
- Crosignani A, Spina S, Marrazzo F, et al. Intravenous fluid therapy in patients with severe acute pancreatitis admitted to the intensive care unit: a narrative review. Ann Intensive Care. 2022. PMID: 36251136. doi:10.1186/s13613-022-01072-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。